Clinical and Biochemical Evaluation of Lozenges Containing <i>Lactobacillus reuteri</i> as an Adjunct to Non‐Surgical Periodontal Therapy in Chronic Periodontitis

Abstract

Lozenges containing L. reuteri may be a useful supplement in moderately deep pockets of patients with CP. Low MMP-8 and high TIMP-1 levels may indicate the role of the lozenges in reduction of inflammation-associated markers up to day 180.